You are here

obesity

A decade after its first approval, FDA expands weight loss pill's label for use in adolescents

Endpoints

Tue, 06/28/22 - 10:44 am

Innovent catching up with Lilly, Novo Nordisk thanks to phase 2 obesity data

Fierce Biotech

Wed, 06/8/22 - 10:34 am

clinical trials

Weigh to Go: Gelesis Boasts Positive Results for Weight Loss Treatment

BioSpace

Thu, 05/5/22 - 10:24 am

PureTech Health

Gelesis Holdings

clinical trials

Novo's Wegovy supply rebound on track for later this year as demand stays strong

Fierce Pharma

Mon, 05/2/22 - 11:04 am

Lilly's tirzepatide clears high bar set by Novo's Wegovy in obesity

Fierce Biotech

Thu, 04/28/22 - 10:53 am

Study: PD-L1 may have Application in Obesity Treatment

BioSpace

Thu, 03/10/22 - 11:04 am

Novo Nordisk, citing strong Wegovy demand, doubles 2025 sales target for obesity franchise

Fierce Pharma

Thu, 03/3/22 - 10:54 am

Novo Nordisk gets NICE okay for obesity drug Wegovy

Pharmaforum

Tue, 02/8/22 - 09:55 am

Pfizer accuses former employees of 'treachery' in stealing trade secrets to form Regor Therapeutics

Fierce Biotech

Thu, 02/3/22 - 10:34 am

Novo Nordisk's Wegovy, hamstrung by Catalent FDA write-up, could correct course by mid-2022: analysts

Fierce Pharma

Thu, 01/27/22 - 10:47 am

Novo Nordisk moves to strengthen obesity efforts

Pharmaforum

Mon, 01/17/22 - 10:27 am

EraCal Therapeutics

JPM 2022: Eli Lilly CEO mulls using Novo's double-branding trick on tirzepatide—one obesity, one diabetes

Fierce Pharma

Wed, 01/12/22 - 11:10 am

Novo Nordisk's weight loss drug Wegovy to run short amid contract manufacturer hiccup

Fierce Pharma

Mon, 12/20/21 - 10:50 am

drug manufacturing

Novo Nordisk nears EU approval of obesity drug Wegovy

Pharmaforum

Fri, 11/12/21 - 10:34 am

Demand for new obesity drug outstripping supply

Beckers Hospital Review

Wed, 11/3/21 - 11:29 pm

Novo Nordisk teams with CVS Health on obesity support program ahead of Wegovy DTC launch

Fierce Pharma

Tue, 10/19/21 - 10:50 am

pharma marketing

On a quest to challenge Novo Nordisk in obesity, transpacific startup picks up $70M — and a pair of seasoned execs

Endpoints

Tue, 10/12/21 - 11:43 pm

Sciwind Biosciences

Altimmune slips after posting 12-week data from Phase 1 trial for weight loss therapy

Seeking Alpha

Tue, 09/28/21 - 11:14 pm

clinical trials

Novo Nordisk Foundation teams up with Broad Institute, Harvard for diabetes, obesity research hub

Fierce Biotech

Wed, 09/15/21 - 10:54 am

Novo Nordisk Foundation

Broad Institute

Versanis Bio unveils $70M and a Novartis drug ready for Phase 2 test in obesity

MedCity News

Tue, 08/31/21 - 10:05 pm

clinical trials

Pages